Published in AIDS Weekly, March 15th, 2004
In a recent study from Seattle, the "role of T-cell immunity in virus control during chronic infection was examined in 79 human immunodeficiency virus type 1 (HIV-1)-infected subjects randomized to receive antiretroviral therapy."
"HIV-1 p24-specific responses were detected in 20% of the subjects at baseline, increasing to 28% of the subjects at weeks 16-24," reported U. Malhotra and coauthors at the Fred Hutchinson Cancer Research Center.
"Induction of virologic suppression was associated with lower plasma HIV-1 RNA levels and a higher...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.